Global and Japan Juvenile Macular Degeneration Treatment Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Juvenile Macular Degeneration Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Avacincaptad Pegol Sodium
1.2.3 Echothiophate Iodide
1.2.4 Emixustat Hydrochloride
1.2.5 FAB-111
1.2.6 Others
1.3 Market by Application
1.3.1 Global Juvenile Macular Degeneration Treatment Market Share by Application: 2020 VS 2026
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Juvenile Macular Degeneration Treatment Market Perspective (2015-2026)
2.2 Global Juvenile Macular Degeneration Treatment Growth Trends by Regions
2.2.1 Juvenile Macular Degeneration Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Juvenile Macular Degeneration Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Juvenile Macular Degeneration Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Juvenile Macular Degeneration Treatment Players by Market Size
3.1.1 Global Top Juvenile Macular Degeneration Treatment Players by Revenue (2015-2020)
3.1.2 Global Juvenile Macular Degeneration Treatment Revenue Market Share by Players (2015-2020)
3.2 Global Juvenile Macular Degeneration Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Juvenile Macular Degeneration Treatment Revenue
3.4 Global Juvenile Macular Degeneration Treatment Market Concentration Ratio
3.4.1 Global Juvenile Macular Degeneration Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Juvenile Macular Degeneration Treatment Revenue in 2019
3.5 Key Players Juvenile Macular Degeneration Treatment Area Served
3.6 Key Players Juvenile Macular Degeneration Treatment Product Solution and Service
3.7 Date of Enter into Juvenile Macular Degeneration Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Juvenile Macular Degeneration Treatment Breakdown Data by Type (2015-2026)
4.1 Global Juvenile Macular Degeneration Treatment Historic Market Size by Type (2015-2020)
4.2 Global Juvenile Macular Degeneration Treatment Forecasted Market Size by Type (2021-2026)
5 Juvenile Macular Degeneration Treatment Breakdown Data by Application (2015-2026)
5.1 Global Juvenile Macular Degeneration Treatment Historic Market Size by Application (2015-2020)
5.2 Global Juvenile Macular Degeneration Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Juvenile Macular Degeneration Treatment Market Size (2015-2026)
6.2 North America Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020)
6.3 North America Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020)
6.4 North America Juvenile Macular Degeneration Treatment Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Juvenile Macular Degeneration Treatment Market Size (2015-2026)
7.2 Europe Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020)
7.3 Europe Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020)
7.4 Europe Juvenile Macular Degeneration Treatment Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Juvenile Macular Degeneration Treatment Market Size (2015-2026)
8.2 China Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020)
8.3 China Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020)
8.4 China Juvenile Macular Degeneration Treatment Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Juvenile Macular Degeneration Treatment Market Size (2015-2026)
9.2 Japan Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020)
9.3 Japan Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020)
9.4 Japan Juvenile Macular Degeneration Treatment Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Juvenile Macular Degeneration Treatment Market Size (2015-2026)
10.2 Southeast Asia Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020)
10.3 Southeast Asia Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020)
10.4 Southeast Asia Juvenile Macular Degeneration Treatment Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Acucela Inc.
11.1.1 Acucela Inc. Company Details
11.1.2 Acucela Inc. Business Overview
11.1.3 Acucela Inc. Juvenile Macular Degeneration Treatment Introduction
11.1.4 Acucela Inc. Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020))
11.1.5 Acucela Inc. Recent Development
11.2 Alkeus Pharmaceuticals Inc
11.2.1 Alkeus Pharmaceuticals Inc Company Details
11.2.2 Alkeus Pharmaceuticals Inc Business Overview
11.2.3 Alkeus Pharmaceuticals Inc Juvenile Macular Degeneration Treatment Introduction
11.2.4 Alkeus Pharmaceuticals Inc Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020)
11.2.5 Alkeus Pharmaceuticals Inc Recent Development
11.3 Astellas Pharma Inc
11.3.1 Astellas Pharma Inc Company Details
11.3.2 Astellas Pharma Inc Business Overview
11.3.3 Astellas Pharma Inc Juvenile Macular Degeneration Treatment Introduction
11.3.4 Astellas Pharma Inc Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020)
11.3.5 Astellas Pharma Inc Recent Development
11.4 Copernicus Therapeutics Inc
11.4.1 Copernicus Therapeutics Inc Company Details
11.4.2 Copernicus Therapeutics Inc Business Overview
11.4.3 Copernicus Therapeutics Inc Juvenile Macular Degeneration Treatment Introduction
11.4.4 Copernicus Therapeutics Inc Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020)
11.4.5 Copernicus Therapeutics Inc Recent Development
11.5 Grupo Ferrer Internacional SA
11.5.1 Grupo Ferrer Internacional SA Company Details
11.5.2 Grupo Ferrer Internacional SA Business Overview
11.5.3 Grupo Ferrer Internacional SA Juvenile Macular Degeneration Treatment Introduction
11.5.4 Grupo Ferrer Internacional SA Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020)
11.5.5 Grupo Ferrer Internacional SA Recent Development
11.6 Iris Pharma
11.6.1 Iris Pharma Company Details
11.6.2 Iris Pharma Business Overview
11.6.3 Iris Pharma Juvenile Macular Degeneration Treatment Introduction
11.6.4 Iris Pharma Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020)
11.6.5 Iris Pharma Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Juvenile Macular Degeneration Treatment Introduction
11.7.4 Sanofi Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020)
11.7.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Juvenile Macular Degeneration Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Avacincaptad Pegol Sodium
Table 4. Key Players of Echothiophate Iodide
Table 5. Key Players of Emixustat Hydrochloride
Table 6. Key Players of FAB-111
Table 7. Key Players of Others
Table 8. Global Juvenile Macular Degeneration Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Juvenile Macular Degeneration Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Juvenile Macular Degeneration Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Juvenile Macular Degeneration Treatment Market Share by Regions (2015-2020)
Table 12. Global Juvenile Macular Degeneration Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Juvenile Macular Degeneration Treatment Market Share by Regions (2021-2026)
Table 14. Juvenile Macular Degeneration Treatment Market Market Trends
Table 15. Juvenile Macular Degeneration Treatment Market Drivers
Table 16. Juvenile Macular Degeneration Treatment Market Challenges
Table 17. Juvenile Macular Degeneration Treatment Market Restraints
Table 18. Global Juvenile Macular Degeneration Treatment Revenue by Players (2015-2020) (US$ Million)
Table 19. Global Juvenile Macular Degeneration Treatment Market Share by Players (2015-2020)
Table 20. Global Top Juvenile Macular Degeneration Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Juvenile Macular Degeneration Treatment as of 2019)
Table 21. Global Juvenile Macular Degeneration Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Juvenile Macular Degeneration Treatment Product Solution and Service
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020) (US$ Million)
Table 26. Global Juvenile Macular Degeneration Treatment Market Size Share by Type (2015-2020)
Table 27. Global Juvenile Macular Degeneration Treatment Revenue Market Share by Type (2021-2026)
Table 28. Global Juvenile Macular Degeneration Treatment Market Size Share by Application (2015-2020)
Table 29. Global Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020) (US$ Million)
Table 30. Global Juvenile Macular Degeneration Treatment Market Size Share by Application (2021-2026)
Table 31. North America Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020) (US$ Million)
Table 32. North America Juvenile Macular Degeneration Treatment Market Share by Type (2015-2020)
Table 33. North America Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020) (US$ Million)
Table 34. North America Juvenile Macular Degeneration Treatment Market Share by Application (2015-2020)
Table 35. North America Juvenile Macular Degeneration Treatment Market Size by Country (US$ Million) (2015-2020)
Table 36. North America Juvenile Macular Degeneration Treatment Market Share by Country (2015-2020)
Table 37. Europe Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020) (US$ Million)
Table 38. Europe Juvenile Macular Degeneration Treatment Market Share by Type (2015-2020)
Table 39. Europe Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020) (US$ Million)
Table 40. Europe Juvenile Macular Degeneration Treatment Market Share by Application (2015-2020)
Table 41. Europe Juvenile Macular Degeneration Treatment Market Size by Country (US$ Million) (2015-2020)
Table 42. Europe Juvenile Macular Degeneration Treatment Market Share by Country (2015-2020)
Table 43. China Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020) (US$ Million)
Table 44. China Juvenile Macular Degeneration Treatment Market Share by Type (2015-2020)
Table 45. China Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020) (US$ Million)
Table 46. China Juvenile Macular Degeneration Treatment Market Share by Application (2015-2020)
Table 47. China Juvenile Macular Degeneration Treatment Market Size by Region (US$ Million) (2015-2020)
Table 48. China Juvenile Macular Degeneration Treatment Market Share by Region (2015-2020)
Table 49. Japan Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020) (US$ Million)
Table 50. Japan Juvenile Macular Degeneration Treatment Market Share by Type (2015-2020)
Table 51. Japan Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020) (US$ Million)
Table 52. Japan Juvenile Macular Degeneration Treatment Market Share by Application (2015-2020)
Table 53. Japan Juvenile Macular Degeneration Treatment Market Size by Country (US$ Million) (2015-2020)
Table 54. Japan Juvenile Macular Degeneration Treatment Market Share by Country (2015-2020)
Table 55. Southeast Asia Juvenile Macular Degeneration Treatment Market Size by Type (2015-2020) (US$ Million)
Table 56. Southeast Asia Juvenile Macular Degeneration Treatment Market Share by Type (2015-2020)
Table 57. Southeast Asia Juvenile Macular Degeneration Treatment Market Size by Application (2015-2020) (US$ Million)
Table 58. Southeast Asia Juvenile Macular Degeneration Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Juvenile Macular Degeneration Treatment Market Size by Country (US$ Million) (2015-2020)
Table 60. Southeast Asia Juvenile Macular Degeneration Treatment Market Share by Country (2015-2020)
Table 61. Acucela Inc. Company Details
Table 62. Acucela Inc. Business Overview
Table 63. Acucela Inc. Product
Table 64. Acucela Inc. Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020) (US$ Million)
Table 65. Acucela Inc. Recent Development
Table 66. Alkeus Pharmaceuticals Inc Company Details
Table 67. Alkeus Pharmaceuticals Inc Business Overview
Table 68. Alkeus Pharmaceuticals Inc Product
Table 69. Alkeus Pharmaceuticals Inc Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020) (US$ Million)
Table 70. Alkeus Pharmaceuticals Inc Recent Development
Table 71. Astellas Pharma Inc Company Details
Table 72. Astellas Pharma Inc Business Overview
Table 73. Astellas Pharma Inc Product
Table 74. Astellas Pharma Inc Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020) (US$ Million)
Table 75. Astellas Pharma Inc Recent Development
Table 76. Copernicus Therapeutics Inc Company Details
Table 77. Copernicus Therapeutics Inc Business Overview
Table 78. Copernicus Therapeutics Inc Product
Table 79. Copernicus Therapeutics Inc Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020) (US$ Million)
Table 80. Copernicus Therapeutics Inc Recent Development
Table 81. Grupo Ferrer Internacional SA Company Details
Table 82. Grupo Ferrer Internacional SA Business Overview
Table 83. Grupo Ferrer Internacional SA Product
Table 84. Grupo Ferrer Internacional SA Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020) (US$ Million)
Table 85. Grupo Ferrer Internacional SA Recent Development
Table 86. Iris Pharma Company Details
Table 87. Iris Pharma Business Overview
Table 88. Iris Pharma Product
Table 89. Iris Pharma Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020) (US$ Million)
Table 90. Iris Pharma Recent Development
Table 91. Sanofi Company Details
Table 92. Sanofi Business Overview
Table 93. Sanofi Product
Table 94. Sanofi Revenue in Juvenile Macular Degeneration Treatment Business (2015-2020) (US$ Million)
Table 95. Sanofi Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Juvenile Macular Degeneration Treatment Market Share by Type: 2020 VS 2026
Figure 2. Avacincaptad Pegol Sodium Features
Figure 3. Echothiophate Iodide Features
Figure 4. Emixustat Hydrochloride Features
Figure 5. FAB-111 Features
Figure 6. Others Features
Figure 7. Global Juvenile Macular Degeneration Treatment Market Share by Application: 2020 VS 2026
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Homecare Case Studies
Figure 11. Juvenile Macular Degeneration Treatment Report Years Considered
Figure 12. Global Juvenile Macular Degeneration Treatment Market Size (US$ Million), YoY Growth 2015-2026
Figure 13. Global Juvenile Macular Degeneration Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Juvenile Macular Degeneration Treatment Market Share by Regions (2021-2026)
Figure 15. Global Juvenile Macular Degeneration Treatment Market Share by Players in 2019
Figure 16. Global Top Juvenile Macular Degeneration Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Juvenile Macular Degeneration Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Juvenile Macular Degeneration Treatment Revenue in 2019
Figure 18. North America Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. United States Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Europe Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Rest of Europe Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Asia-Pacific Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. China Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Japan Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. South Korea Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Southeast Asia Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. India Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Australia Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Rest of Asia-Pacific Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Latin America Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Mexico Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Brazil Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Middle East & Africa Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Turkey Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Saudi Arabia Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. UAE Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Rest of Middle East & Africa Juvenile Macular Degeneration Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Acucela Inc. Revenue Growth Rate in Juvenile Macular Degeneration Treatment Business (2015-2020)
Figure 46. Alkeus Pharmaceuticals Inc Revenue Growth Rate in Juvenile Macular Degeneration Treatment Business (2015-2020)
Figure 47. Astellas Pharma Inc Revenue Growth Rate in Juvenile Macular Degeneration Treatment Business (2015-2020)
Figure 48. Copernicus Therapeutics Inc Revenue Growth Rate in Juvenile Macular Degeneration Treatment Business (2015-2020)
Figure 49. Grupo Ferrer Internacional SA Revenue Growth Rate in Juvenile Macular Degeneration Treatment Business (2015-2020)
Figure 50. Iris Pharma Revenue Growth Rate in Juvenile Macular Degeneration Treatment Business (2015-2020)
Figure 51. Sanofi Revenue Growth Rate in Juvenile Macular Degeneration Treatment Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed